Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Cognitive Impairment in Epilepsy
NCT04417543Phase 1Completed
- Sponsor
- Assiut University
- Start
- Oct 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cognitive impairment comparing Memantine Group with Placebo Group (2 arms). Primary endpoints: Memory Assessment Scale at 1.5 years, Wechsler Adult Intelligence Scale at 1.5 years and 1 more. Started Oct 2018; status: completed.
02
Drugs
memantine
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT04417543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04417543.